|
1
|
Van der Velden SK, Shadid NH, Nelemans PJ
and Sommer A: How specific are venous symptoms for diagnosis of
chronic venous disease? Phlebology. 29:580–586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tudoraşcu I, Sfredel V, Riza AL, Miulescu
Dănciulescu R, Ianoşi SL and Dănoiu S: Motor unit changes in normal
aging: A brief review. Rom J Morphol Embryol. 55:1295–1301.
2014.PubMed/NCBI
|
|
3
|
Breu FX and Wollmann JC: Clinical and
technical follow-up after sclerotherapy. Dermatol Surg. 36 Suppl
2:1004–1009. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heck M, Faulhaber J, Breu FX and Schneider
SW: Foam sclerotherapy. Uses and indications in dermatology and
phlebology. Hautarzt. 63:493–505. 2012.(In German).
|
|
5
|
Perrin M, Eklof B, VAN Rij A, Labropoulos
N, Vasquez M, Nicolaides A, Blattler W, Bouhassira D, Bouskela E,
Carpentier P, et al: Venous symptoms: The SYM Vein Consensus
statement developed under the auspices of the European Venous
Forum. Int Angiol. 35:374–398. 2016.PubMed/NCBI
|
|
6
|
Hamel-Desnos C, Ouvry P, Benigni JP,
Boitelle G, Schadeck M, Desnos P and Allaert FA: Comparison of 1%
and 3% polidocanol foam in ultrasound guided sclerotherapy of the
great saphenous vein: A randomised, double-blind trial with 2 year
follow-up. ‘The 3/1 Study’. Eur J Vasc Endovasc Surg. 34:723–730.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen CH, Chiu CS and Yang CH:
Ultrasound-guided foam sclerotherapy for treating incompetent great
saphenous veins - results of 5 years of analysis and morphologic
evolvement study. Dermatol Surg. 38:851–857. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prieto V, Zhang P and Sadick NS:
Comparison of a combination diode laser and radiofrequency device
(Polaris) and a long-pulsed 1064-nm Nd:YAG laser (Lyra) on leg
telangiectases. Histologic and immunohistochemical analysis. J
Cosmet Laser Ther. 8:191–195. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Caruntu C, Negrei C, Boda D, Constantin C,
Caruntu A and Neagu M: Biotechnological advances for diagnosis of
peripheral diabetic neuropathy. Rom Biotech Lett. 19:9846–9858.
2014.
|
|
10
|
Breu FX, Guggenbichler S and Wollmann JC:
2nd European Consensus Meeting on foam sclerotherapy 2006,
Tegernsee, Germany. Vasa. 37 Suppl 71:1–29. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goldman MP, Guex JJ and Weiss RA:
Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins.
5th. Saunders; Philadelphia: pp. 1–416. 2011
|
|
12
|
Ianosi S, Neagoe D, Calbureanu M and
Ianosi G: Investigator-blind, placebo-controlled, randomized
comparative study on combined vacuum and intense pulsed light
versus intense pulsed light devices in both comedonal and
papulopustular acne. J Cosmet Laser Ther. 15:248–254. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nijsten T, van den Bos RR, Goldman MP,
Kockaert MA, Proebstle TM, Rabe E, Sadick NS, Weiss RA and Neumann
MH: Minimally invasive techniques in the treatment of saphenous
varicose veins. J Am Acad Dermatol. 60:110–119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guex JJ, Schliephake DE, Otto J, Mako S
and Allaert FA: The French polidocanol study on long-term side
effects: A survey covering 3,357 patient years. Dermatol Surg. 36
Suppl 2:993–1003. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sadick NS: Laser treatment of leg veins.
Skin Therapy Lett. 9:6–9. 2004.PubMed/NCBI
|
|
16
|
Rabe E, Breu FX, Cavezzi A, Coleridge
Smith P, Frullini A, Gillet JL, Guex JJ, Hamel-Desnos C, Kern P,
Partsch B, et al: Guideline Group: European guidelines for
sclerotherapy in chronic venous disorders. Phlebology. 29:338–354.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Branisteanu DE, Nichifor M, Dorobat CM,
Branisteanu DC, Petrariu FD, Molodoi AD, Radu DC and Boda D: Use of
textile biomaterials for the topic treatment of chronic venous
disease. Rom Biotechnol Lett. 20:10618–10625. 2015.
|
|
18
|
Rabe E, Schliephake D, Otto J, Breu FX and
Pannier F: Sclerotherapy of telangiectases and reticular veins: A
double-blind, randomized, comparative clinical trial of
polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI
study). Phlebology. 25:124–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Uncu H: Sclerotherapy: A study comparing
polidocanol in foam and liquid form. Phlebology. 25:44–49. 2010.
View Article : Google Scholar : PubMed/NCBI
|
